Ramin Farhood

À propos de l'auteur

Dr. RAMIN FARHOOD, senior VP at SSI Strategy, has over twenty-five years in patient-centric medical strategy. Previously at Novartis, he launched the world’s first gene therapy for spinal muscular atrophy. Farhood cofounded the Medical Affairs Professional Society (MAPS) and the Immunoglobulin National Society (IgNS) and cohosts The Emerging Biotech Leader podcast.

Voices of Oncology
À paraître
Nouveauté
Meilleures ventes
Prévente
Promotion
Voices of Oncology Fostering a Collaborative Community of Experts to Accelerate Cancer Cures

Kirk V. Shepard, Ramin Farhood